BC Atorvastatin Tablet 40mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 43.38mg
Tablet · Prescription medication
BC World Pharm. Co., Ltd.
MFDS item code 201405877 · Approved 2014.12.15
This product's status changed to Expired on 2024.12.15. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia and prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
This medication is used to reduce the risk of cardiovascular diseases. Specifically, it lowers the risk of myocardial infarction and stroke in adults with multiple risk factors for coronary heart disease and in patients with type 2 diabetes. Additionally, it helps reduce the risk of non-fatal myocardial infarction, stroke, the need for vascular interventions, congestive heart failure hospitalizations, and angina in patients who already have coronary heart disease. Furthermore, it is effective as an adjunct to diet in managing cholesterol and triglyceride levels in patients with primary hypercholesterolemia or mixed dyslipidemia, and can also be used in patients with specific beta-lipoproteinemia or elevated triglycerides who do not respond adequately to diet. Therefore, this medication is used for the improvement and management of risk factors associated with cardiovascular diseases and hyperlipidemia.
Patients receiving atorvastatin before and during treatment should follow a standard cholesterol-lowering diet. This drug may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose should be adjusted accordingly. Because the treatment goal is to reduce LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: The efficacy and safety in elderly patients aged 70 years or older are generally similar to those in the usual adult patient population.
This drug may have risks for muscle problems; thus, if there are severe symptoms of muscle pain or weakness, discontinue use immediately and consult a doctor. This drug should not be taken by individuals with certain diseases or by pregnant women, children, etc. Patients with impaired liver or kidney function, alcoholics, and the elderly should use this drug with caution and regular check-ups are necessary. If symptoms such as liver function abnormalities, allergic reactions, or skin rashes appear while taking this drug, inform a doctor immediately. Interactions may occur when taken with other medications, so if you are already taking any, be sure to inform your doctor or pharmacist. Women of childbearing age must use appropriate contraception while taking this drug and should avoid use if pregnant or potentially pregnant. Nursing mothers should also avoid taking this drug and it is safest to discontinue breastfeeding while on this medication. There is no specific antidote for overdose, so appropriate treatment should be administered based on symptoms, and liver function and muscle status should be regularly monitored. This drug should be kept out of reach of children and stored in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This drug must be stored in a tightly sealed container to prevent exposure to air or moisture. Additionally, it should be kept at room temperature that is not excessively hot or cold, ideally between 1 degree and 30 degrees Celsius.
White round film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Hydrate 43.38mg
Tablet · Prescription medication
BC World Pharm. Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.